Meeting
2015 Genitourinary Cancers Symposium
Third-line therapy in metastatic renal cell carcinoma: Results from the International mRCC Database Consortium.
Authors
Daniel Yick Chin Heng
Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada
Daniel Yick Chin Heng , Connor Wells , Frede Donskov , Brian I. Rini , Jae-Lyun Lee , Georg A. Bjarnason , Benoit Beuselinck , Martin Smoragiewicz , Ajjai Shivaram Alva , Sandy Srinivas , Lori Wood , Haru Yamamoto , D. Scott Ernst , Sumanta Kumar Pal , Takeshi Yuasa , Reuben James Broom , Ravindran Kanesvaran , Aristotelis Bamias , Jennifer J. Knox , Toni K. Choueiri
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Renal Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 33, 2015 (suppl 7; abstr 430)
DOI
10.1200/jco.2015.33.7_suppl.430
Abstract #
430
Poster Bd #
C22
Abstract Disclosures
Similar Posters
Poster
2012 Genitourinary Cancers Symposium
Efficacy and safety of pazopanib as a subsequent treatment after failure of other targeted agents in patients with metastatic renal cell carcinoma (mRCC).
First Author: Jiahuai Tan
Poster
2017 Genitourinary Cancers Symposium
Fourth-line targeted therapy in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).
First Author: Igor Stukalin
Poster
2016 ASCO Annual Meeting
Association of high cost sharing and target therapy initiation among Medicare patients with metastatic renal cell carcinoma.
First Author: Pengxiang Li
Poster
2014 Genitourinary Cancers Symposium
Duration of targeted therapy in metastatic renal cell carcinoma patients with ECOG PS>2.
First Author: Ilya Tsimafeyeu